Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Phage / Product Type

  2.3.2 Market Size By Administration / Route

  2.3.3 Market Size By Application / Use Case

  2.3.4 Market Size By End-User / Customer Type

        2.3.5 Market Size By Target Bacterial Indication / Disease

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Application Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 R&D & Technological Insights

4.1.1 Advances in CRISPR-engineered bacteriophages and synthetic biology applications

4.1.2 Development of phage delivery systems: hydrogels, nanocarriers, inhalable aerosols

4.1.3 Combination therapies: phage-antibiotic synergy studies

4.1.4 Regulatory pathways for personalized phage therapy

4.1.5 Stability, shelf-life, and storage optimization for phage formulations

4.2 Market & Commercial Insights

4.2.1 Cost-per-treatment comparison with conventional antibiotics

4.2.2 Market penetration in regions with high antimicrobial resistance (AMR)

4.2.3 Partnerships between biotech startups and large pharmaceutical companies

4.2.4 Investment trends in phage banks and production facilities

4.2.5 Licensing and intellectual property opportunities for proprietary phage cocktails

4.3 Clinical & Patient Insights

4.3.1 Adoption in compassionate-use programs and clinical trials

4.3.2 Patient compliance and administration convenience (oral vs. injectable)

4.3.3 Reported efficacy rates by bacterial strain

4.3.4 Safety and immunogenicity profiling in human and veterinary applications

4.3.5 Expansion potential in emerging markets for livestock and aquaculture

4.4 Strategic & Competitive Insights

4.4.1 Integration with diagnostic tools for precision therapy

4.4.2 Key differentiators: broad-host vs. narrow-host phages

4.4.3 Growth opportunities in personalized medicine and targeted infection treatment

4.4.4 Collaboration trends with hospitals, research institutes, and food safety companies

4.4.5 Emerging market niches: chronic infections, AMR hotspots, biofilm-associated infections

5. Phage Therapy Market Segmental Analysis & Forecast, By Phage / Product Type, 2022 – 2035, Value (USD Billion)

5.1 Introduction

 5.2 dsDNA Bacteriophage

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

     5.3 ssDNA Bacteriophage

     5.4 ssRNA Bacteriophage

     5.5 Phage Cocktails / Engineered Preparations

     5.6 Delivery / Formulation Types

6. Phage Therapy Market Segmental Analysis & Forecast, By Administration / Route, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

    6.2 Oral

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

    6.3 Topical / External Application

    6.4 Injectable / Surgical Administration

7. Phage Therapy Market Segmental Analysis & Forecast, By Application / Use Case, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

    7.2 Human Therapeutics

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

    7.3 Veterinary Medicine

    7.4 Agriculture & Crop Protection

    7.5 Aquaculture

    7.6 Food Safety & Preservation

    7.7 Research & Development / Diagnostics

8. Phage Therapy Market Segmental Analysis & Forecast, By End-User / Customer Type, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals & Clinics

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

    8.3 Pharmaceutical & Biotechnology Companies

    8.4 Research & Academic Institutions

    8.5 Veterinary Care Providers

    8.6 Food & Beverage / Processing Industry

    8.7 Agricultural Enterprises

9. Phage Therapy Market Segmental Analysis & Forecast, By Target Bacterial Indication / Disease, 2022 – 2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Urinary Tract Infections

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022 – 2035 

  9.3 Wound & Skin Infections

  9.4 Respiratory Infections

         9.5 Bone & Orthopedic Infections

         9.6 Chronic Conditions

         9.7 Other Pathogen-Specific Indications

10. Phage Therapy Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

  10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Phage Therapy Market Size & Forecast, By Phage / Product Type, 2022 – 2035

  10.2.3 Phage Therapy Market Size & Forecast, By Administration / Route, 2022 – 2035

  10.2.4 Phage Therapy Market Size & Forecast, By Application / Use Case, 2022 – 2035

  10.2.5 Phage Therapy Market Size & Forecast, By End-User / Customer Type, 2022 – 2035

  10.2.6 Phage Therapy Market Size & Forecast, By Target Bacterial Indication / Disease, 2022 – 2035

  10.2.7 Phage Therapy Market Size & Forecast, By Country, 2022 – 2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Phage Therapy Market Size & Forecast, By Phage / Product Type, 2022 – 2035

 10.3.3 Phage Therapy Market Size & Forecast, By Administration / Route, 2022 – 2035

 10.3.4 Phage Therapy Market Size & Forecast, By Application / Use Case, 2022 – 2035

 10.3.5 Phage Therapy Market Size & Forecast, By End-User / Customer Type, 2022 – 2035

 10.3.6 Phage Therapy Market Size & Forecast, By Target Bacterial Indication / Disease, 2022 – 2035

 10.3.7 Phage Therapy Market Size & Forecast, By Country, 2022 – 2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Phage Therapy Market Size & Forecast, By Phage / Product Type, 2022 – 2035

 10.4.3 Phage Therapy Market Size & Forecast, By Administration / Route, 2022 – 2035

 10.4.4 Phage Therapy Market Size & Forecast, By Application / Use Case, 2022 – 2035

 10.4.5 Phage Therapy Market Size & Forecast, By End-User / Customer Type, 2022 – 2035

 10.4.6 Phage Therapy Market Size & Forecast, By Target Bacterial Indication / Disease, 2022 – 2035

 10.4.7 Phage Therapy Market Size & Forecast, By Country, 2022 – 2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Phage Therapy Market Size & Forecast, By Phage / Product Type, 2022 – 2035

 10.5.3 Phage Therapy Market Size & Forecast, By Administration / Route, 2022 – 2035

 10.5.4 Phage Therapy Market Size & Forecast, By Application / Use Case, 2022 – 2035

 10.5.5 Phage Therapy Market Size & Forecast, By End-User / Customer Type, 2022 – 2035

 10.5.6 Phage Therapy Market Size & Forecast, By Target Bacterial Indication / Disease, 2022 – 2035

 10.5.7 Phage Therapy Market Size & Forecast, By Country, 2022 – 2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Phage Therapy Market Size & Forecast, By Phage / Product Type, 2022 – 2035

 10.6.3 Phage Therapy Market Size & Forecast, By Administration / Route, 2022 – 2035

 10.6.4 Phage Therapy Market Size & Forecast, By Application / Use Case, 2022 – 2035

 10.6.5 Phage Therapy Market Size & Forecast, By End-User / Customer Type, 2022 – 2035

 10.6.6 Phage Therapy Market Size & Forecast, By Target Bacterial Indication / Disease, 2022 – 2035

 10.6.7 Phage Therapy Market Size & Forecast, By Country, 2022 – 2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 Egypt

  10.6.7.5 South Africa

  10.6.7.6 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2022 – 2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

11.6.1 Adaptive Phage Therapeutics

    11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

  11.6.1.4 SWOT Analysis

11.6.2 Armata Pharmaceuticals

11.6.3 Locus Biosciences

11.6.4 Intralytix, Inc.

11.6.5 Pherecydes Pharma

11.6.6 EnBiotix, Inc.

11.6.7 Eligo Bioscience

11.6.8 ContraFect Corporation

11.6.9 Micreos B.V.

11.6.10 Nextbiotics

11.6.11 Phagomed Biopharma GmbH

11.6.12 PhagePro, Inc.

11.6.13 TechnoPhage

11.6.14 Proteon Pharmaceuticals

11.6.15 Eliava BioPreparations

11.6.16 Fixed-Phage Ltd.

11.6.17 BiomX Ltd.

11.6.18 iNtODEWORLD

11.6.19 Phagelux

11.6.20 InnoPhage Ltd.

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures